STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on May 1, 2025

iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング サービスを開始し、AIを活用した不整脈検出の進化を推進します。

iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング サービスを開始し、AIを活用した不整脈検出の進化を推進します。

日本で「Zio ECG記録・解析システム」として商業的に導入されたiRhythm Zio®長期連続心電図モニタリングサービスは、AIを活用した連続的で中断のない心電図モニタリングを最長14日間提供します。 日本における不整脈の早期かつ正確な検出に対する需要が高まる中、本製品の発売は適切なタイミングです。日本は世界第2位の携帯型/ 装着型心電計市場であり、高齢化に伴い不整脈の有病率が上昇すると予想されています1-3。   サンフランシスコ, May 01, 2025 (GLOBE NEWSWIRE) -- …

Nutanix Announces Date and Conference Call Information for Third Quarter Fiscal Year 2025 Financial Results

Nutanix Announces Date and Conference Call Information for Third Quarter Fiscal Year 2025 Financial Results

SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the third quarter of fiscal year 2025, which ended April 30, 2025, after …

Lakeland Fire + Safety Declares Cash Dividend for Second Quarter 2026

Lakeland Fire + Safety Declares Cash Dividend for Second Quarter 2026

HUNTSVILLE, Ala., May 01, 2025 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today …

Sutro Biopharma to Participate in Upcoming Investor Conferences

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will …

DMC Global Reports First Quarter Financial Results

DMC Global Reports First Quarter Financial Results

First quarter sales were $159.3 million, up 5% sequentially and down 5% versus Q1 2024 Net income attributable to DMC was $0.7 million Adjusted net income attributable to DMC* was $2.2 million, or $0.11 per diluted share Adjusted EBITDA attributable to DMC …

Wag! To Report First Quarter 2025 Financial Results on May 12, 2025

Wag! To Report First Quarter 2025 Financial Results on May 12, 2025

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co., (the “Company” or “Wag!”, Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced that it …

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities …

iRhythm Technologies Announces First Quarter 2025 Financial Results

iRhythm Technologies Announces First Quarter 2025 Financial Results

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three …

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

Dosing cohort 3 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers and plan to initiate backfill cohorts in the second half of 2025 Plan to provide a proof of concept data readout in the first half of 2026 Cash of approximately $55.9 million …

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will …

Zoom to Release Financial Results for the First Quarter of Fiscal Year 2026

Zoom to Release Financial Results for the First Quarter of Fiscal Year 2026

SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the first quarter of fiscal year 2026 on Wednesday, May 21, 2025, after the market closes. A live Zoom …

Draganfly Announces Proposed Public Offering of Common Shares & Warrants

Draganfly Announces Proposed Public Offering of Common Shares & Warrants

Saskatoon, SK., May 01, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced it has commenced an underwritten public offering in the United …

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to …

Kura Oncology Reports First Quarter 2025 Financial Results

Kura Oncology Reports First Quarter 2025 Financial Results

– NDA submitted in 1Q 2025 for ziftomenib for the treatment of adult patients with relapsed or refractory AML with an NPM1 mutation – – Data from Phase 1b/2 registration-directed trial of ziftomenib selected for oral presentation at ASCO Annual Meeting – – …

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has …

89bio Reports First Quarter 2025 Financial Results and Corporate Updates

89bio Reports First Quarter 2025 Financial Results and Corporate Updates

– Topline histology data from ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials are expected in 1H 2027 and in 2028, respectively; each trial is designed to support accelerated approval to treat patients with metabolic dysfunction-associated …

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

Generated $78.3 million in net product sales of XDEMVY®, an increase of 217% year over year and 18% over Q4 2024, and dispensed approximately 72,000 bottles to patients Strengthened financial position with approximately $135 million raised in public equity …

GSI Technology, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

GSI Technology, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (NASDAQ: GSIT) today reported financial results for its fourth fiscal quarter and fiscal year ended March 31, 2025. Summary Financial Results Table (in thousands, except per share …

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

-  Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials -  Pliant will reduce its current workforce by approximately 45% -  Closing activities for BEACON-IPF trial ongoing; topline data expected in the …

Inseego Repays $15 million in Remaining Convertible Notes due 2025

Inseego Repays $15 million in Remaining Convertible Notes due 2025

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG) (the “Company”), a global leader in wireless broadband, including 5G mobile broadband, and 5G fixed wireless access (FWA) solutions, today announced that it has completed a major …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service